TGTX
Income statement / Annual
Last year (2023), TG Therapeutics, Inc.'s total revenue was $233.66 M,
an increase of 8,290.02% from the previous year.
In 2023, TG Therapeutics, Inc.'s net income was $12.67 M.
See TG Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$233.66 M
|
$2.79 M
|
$6.69 M
|
$152,000.00
|
$152,000.00
|
$152,000.00
|
$152,381.00
|
$152,381.00
|
$152,381.00
|
$152,381.00
|
| Cost of Revenue |
$14.55 M |
$265,000.00 |
$790,000.00 |
$374,000.00 |
$282,000.00 |
$88,000.00 |
$82,355.00 |
$62,960.00 |
$0.00 |
$0.00 |
| Gross Profit |
$219.11 M |
$2.52 M |
$5.90 M |
-$222,000.00 |
-$130,000.00 |
$64,000.00 |
$70,026.00 |
$89,421.00 |
$152,381.00 |
$152,381.00 |
| Gross Profit Ratio |
0.94 |
0.9 |
0.88 |
-1.46 |
-0.86 |
0.42 |
0.46 |
0.59 |
1 |
1 |
| Research and Development
Expenses |
$76.19 M
|
$112.13 M
|
$198.53 M
|
$151.93 M
|
$148.37 M
|
$153.79 M
|
$96.89 M
|
$66.49 M
|
$43.45 M
|
$31.35 M
|
| General & Administrative
Expenses |
$122.71 M
|
$83.23 M
|
$152.14 M
|
$121.81 M
|
$20.84 M
|
$20.76 M
|
$21.98 M
|
$12.63 M
|
$19.89 M
|
$24.52 M
|
| Selling & Marketing
Expenses |
-$423,000.00
|
$64.05 M
|
$90.86 M
|
$41.52 M
|
$0.00
|
-$5.60 M
|
-$5.65 M
|
-$2.74 M
|
-$4.26 M
|
-$8.73 M
|
| Selling, General &
Administrative Expenses |
$122.28 M
|
$83.23 M
|
$152.14 M
|
$121.81 M
|
$20.84 M
|
$20.76 M
|
$21.98 M
|
$12.63 M
|
$19.89 M
|
$24.52 M
|
| Other Expenses |
$0.00 |
$4.70 M |
$2.31 M |
$542,000.00 |
$1.47 M |
$61,000.00 |
-$58,739.00 |
$393,202.00 |
$1.03 M |
$815,467.00 |
| Operating Expenses |
$198.48 M |
$195.36 M |
$350.67 M |
$273.75 M |
$169.21 M |
$174.55 M |
$118.86 M |
$79.12 M |
$63.33 M |
$55.87 M |
| Cost And Expenses |
$213.03 M |
$195.62 M |
$351.46 M |
$273.75 M |
$169.21 M |
$174.55 M |
$118.86 M |
$79.12 M |
$63.33 M |
$55.87 M |
| Interest Income |
$0.00 |
$10.19 M |
$5.64 M |
$6.33 M |
$5.29 M |
$857,000.00 |
$294,478.00 |
$323,032.00 |
$174,653.00 |
$55,049.00 |
| Interest Expense |
$12.62 M |
$10.19 M |
$5.64 M |
$6.33 M |
$5.29 M |
$1.73 M |
$1.14 M |
$0.00 |
$972,736.00 |
$930,701.00 |
| Depreciation &
Amortization |
$423,000.00
|
$515,000.00
|
$494,000.00
|
$374,000.00
|
$282,000.00
|
$88,000.00
|
$82,355.00
|
$62,960.00
|
$15,452.00
|
$3,931.00
|
| EBITDA |
$26.10 M
|
-$187.63 M
|
-$341.97 M
|
-$272.68 M
|
-$168.50 M
|
-$173.39 M
|
-$118.39 M
|
-$78.91 M
|
-$63.16 M
|
-$55.72 M
|
| EBITDA Ratio |
0.11 |
-67.56 |
-51.2 |
-1796.39 |
-1102.53 |
-1146.79 |
-779.05 |
-518.23 |
-406.72 |
-359.96 |
| Operating Income Ratio
|
0.09
|
-69.24
|
-51.54
|
-1799.96
|
-1112.2
|
-1147.37
|
-779.05
|
-518.23
|
-414.62
|
-365.67
|
| Total Other
Income/Expenses Net |
-$7.57 M
|
-$5.50 M
|
-$3.33 M
|
-$5.79 M
|
-$3.82 M
|
$918,000.00
|
$235,988.00
|
$716,000.00
|
$231,370.00
|
-$60,185.00
|
| Income Before Tax |
$13.06 M |
-$198.34 M |
-$348.10 M |
-$279.38 M |
-$172.87 M |
-$173.48 M |
-$118.48 M |
-$78.25 M |
-$62.95 M |
-$55.78 M |
| Income Before Tax Ratio
|
0.06
|
-71.22
|
-52.04
|
-1838.03
|
-1137.31
|
-1141.33
|
-777.5
|
-513.53
|
-413.1
|
-366.06
|
| Income Tax Expense |
$390,000.00 |
$5.50 M |
$7.45 M |
$6.50 M |
$6.48 M |
-$918,000.00 |
-$235,739.00 |
-$716,234.00 |
-$231,370.00 |
$60,185.00 |
| Net Income |
$12.67 M |
-$203.83 M |
-$355.55 M |
-$285.88 M |
-$179.35 M |
-$173.48 M |
-$118.48 M |
-$78.25 M |
-$62.95 M |
-$55.78 M |
| Net Income Ratio |
0.05 |
-73.19 |
-53.15 |
-1880.78 |
-1179.91 |
-1141.33 |
-777.5 |
-513.53 |
-413.1 |
-366.06 |
| EPS |
0.0893 |
-1.51 |
-2.69 |
-2.48 |
-2.03 |
-2.3 |
-1.91 |
-1.6 |
-1.38 |
-1.64 |
| EPS Diluted |
0.0853 |
-1.51 |
-2.69 |
-2.48 |
-2.03 |
-2.3 |
-1.91 |
-1.6 |
-1.38 |
-1.64 |
| Weighted Average Shares
Out |
$141.96 M
|
$135.41 M
|
$132.22 M
|
$115.33 M
|
$88.37 M
|
$75.47 M
|
$62.07 M
|
$49.04 M
|
$45.65 M
|
$34.07 M
|
| Weighted Average Shares
Out Diluted |
$148.51 M
|
$135.41 M
|
$132.22 M
|
$115.33 M
|
$88.37 M
|
$75.47 M
|
$62.07 M
|
$49.04 M
|
$45.65 M
|
$34.07 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
